electroCore (NASDAQ:ECOR) had its target price reduced by Cantor Fitzgerald from $9.00 to $2.00 in a report issued on Thursday morning, The Fly reports. Cantor Fitzgerald currently has a neutral rating on the stock.
Several other research firms also recently commented on ECOR. Evercore ISI reissued a buy rating and set a $9.00 price target on shares of electroCore in a research note on Wednesday, November 13th. ValuEngine raised shares of electroCore from a hold rating to a buy rating in a research note on Thursday, August 1st. JMP Securities downgraded shares of electroCore from an outperform rating to a market perform rating in a research note on Thursday. BTIG Research reissued a hold rating on shares of electroCore in a research note on Wednesday, August 14th. Finally, Noble Financial reissued a buy rating and set a $11.00 price target on shares of electroCore in a research note on Thursday, August 15th. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The stock currently has a consensus rating of Hold and a consensus price target of $6.95.
Shares of ECOR stock traded down $0.12 during trading hours on Thursday, hitting $1.46. 2,900 shares of the company’s stock were exchanged, compared to its average volume of 144,152. The company has a market capitalization of $43.80 million, a PE ratio of -1.33 and a beta of 2.42. electroCore has a 12-month low of $1.23 and a 12-month high of $10.24. The business’s 50 day simple moving average is $1.95 and its 200-day simple moving average is $2.42. The company has a current ratio of 6.63, a quick ratio of 5.93 and a debt-to-equity ratio of 0.04.
Several institutional investors have recently modified their holdings of the company. Brighton Jones LLC grew its holdings in shares of electroCore by 15.1% in the third quarter. Brighton Jones LLC now owns 52,340 shares of the company’s stock worth $115,000 after purchasing an additional 6,869 shares during the last quarter. Bfsg LLC grew its holdings in shares of electroCore by 34.6% in the third quarter. Bfsg LLC now owns 70,000 shares of the company’s stock worth $153,000 after purchasing an additional 18,000 shares during the last quarter. Valeo Financial Advisors LLC grew its holdings in shares of electroCore by 75.0% in the third quarter. Valeo Financial Advisors LLC now owns 45,500 shares of the company’s stock worth $100,000 after purchasing an additional 19,500 shares during the last quarter. Vanguard Group Inc. grew its holdings in shares of electroCore by 4.8% in the second quarter. Vanguard Group Inc. now owns 664,936 shares of the company’s stock worth $1,330,000 after purchasing an additional 30,671 shares during the last quarter. Finally, BlackRock Inc. grew its holdings in shares of electroCore by 3.7% in the second quarter. BlackRock Inc. now owns 575,248 shares of the company’s stock worth $1,150,000 after purchasing an additional 20,536 shares during the last quarter. Hedge funds and other institutional investors own 10.09% of the company’s stock.
electroCore Company Profile
electroCore, Inc, a bioelectronic medicine company, engages in developing a range of patient-administered non-invasive vagus nerve (VNS) stimulation therapies for the treatment of various conditions in neurology, rheumatology, and other fields. The company is developing gammaCore, a prescription-only non-invasive VNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults.
Further Reading: Outstanding Shares and The Effect on Share Price
Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.